Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments

• المؤلفون الرئيسيون: Marta Hernandez (مؤلف), Natalia Cullell (مؤلف), Marc Cendros (مؤلف), Alexandre Serra-Llovich (مؤلف), Maria J. Arranz (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2024-02-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Decades of pharmacogenetic research have revealed genetic biomarkers of clinical response to antipsychotics. Genetic variants in antipsychotic targets, dopamine and serotonin receptors in particular, and in metabolic enzymes have been associated with the efficacy and toxicity of antipsychotic treatm...